United States: The World Health Organization said on Friday that it had approved its first shot of vaccines against the mpox for use in adults, saying that it is a progression toward eradicating the disease in Africa.
More about the news
This approval is significant for organizations like Vaccines Alliance Gavi and UNICEF as they can now purchase it from Bavarian Nordic A/S.
Buying supplies is, however, a challenge since the product is manufactured by only one company.
According to WHO Director-General Tedros Adhanom Ghebreyesus, “This first (authorization) of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa and in future,” ABC News reported.
Previously, the UN health agency endorsed the two-dose mpox vaccine targeting the adult population who are 18 years and above. As for WHO, even though they did not advise the use of the vaccine for people below the age of 18, in particular cases, vaccines can be given to infants, children, and adolescents “in outbreak settings where the benefits of vaccination outweigh the potential risks.”
What more has the WHO recommended?
The WHO has also pointed out that it has been making an “access and allocation mechanism” to execute an even and fair distribution of mpox tests, treatments, and vaccines to the countries that need them most.
WHO has suggested that a dose could be split in the event that there is a shortage of the vaccine since one dose was proven to be 50 percent effective, and it is important to gather more information on the efficacy of the vaccine when used as a single shot.
About the vaccine
The Bavarian Nordic mpox vaccine was earlier named and approved by several developed countries in Europe and North America during the mpox outbreak in the year 2022.
In millions of adults, doses have proven that the vaccine assists in decelerating the virus distribution, but little is known about children.
Director-general of the Africa Center for Disease Control and Prevention said last month that seventy percent of the patients are below the age of 15 in Congo, where the outbreak is most severe, and children under the age of 15 are the majority of fatalities at 85 percent.
However, the WHO noted that more than 120 countries had confirmed more than 103 thousand legion cases of mpox since the start of the outbreak two years ago, ABC News reported.
As of Sunday, it recorded 723 people in well over a dozen countries in Africa have perished from the disease.